ATH alterity therapeutics limited

They are testing ION464 for MSA and Parkinson's and have it...

  1. 5,999 Posts.
    lightbulb Created with Sketch. 162
    They are testing ION464 for MSA and Parkinson's and have it listed with phase 2 trials. It is a Biogen(BIIB) trial. On Ionis pipeline page.
    This is from the Ionis site-
    [ This investigational antisense oligonucleotide medicine is in a Phase 1 study. It is listed here as a Phase 2 because the medicine is being tested in patients and not healthy volunteers ]

    I have never seen that done before.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $24.99K 2.295M

Buyers (Bids)

No. Vol. Price($)
67 86806314 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 20791616 11
View Market Depth
Last trade - 13.16pm 19/09/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.